Glenmark and Lotus partner on allergic rhinitis spray
The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces. The Swiss subsidiary of […]
The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces. The Swiss subsidiary of […]
ADC Reports EMA’s Validation of MAA for Zynlonta to Treat R/R Diffuse Large B-Cell Lymphoma Published: 29 Oct, 2021 | Tags: ADC, EMA, MAA, Zynlonta, […]
Generic medicines are the backbone of the healthcare system. The expiry of patents of branded drugs is the essential tool in the development of generic […]
Shots: Glenmark has launched Remogliflozin (SGLT2 inhibitors, 100mg, ) + Vildagliptin (DPP4 inhibitors, 50mg,) + Metformin (500/1000mg) as FDC for the management of T2D in […]
Shots: Glenmark is concluding the final, national phase of its MAA process to enable launch of its innovative nasal spray, Ryaltris (olopatadine hydrochloride, 665mcg and […]
The global generics pharmaceutical market has become an intimidating segment of the pharmaceutical drug market which continuously growing and increasing with its accessibility & benefits […]
Shots: Dr. Reddy to acquire Glenmark’s brands Momat Rino (for Russia, Kazakhstan, and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan & Uzbekistan), […]
The US Department of Justice has charged Teva with conspiring with other pharma companies to fix prices for generic drugs. According to an indictment filed […]
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has […]
Shots: The P-III study assessing the efficacy and safety of Favipiravir + SSC vs SCC in 150 mild to moderate patients, randomized within a 48hour […]
Copyright © 2024 | WordPress Theme by MH Themes